Older Men Still Overscreened for Prostate Cancer, Survey Says PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it Apr 11, 2023
FDA Greenlights New First-Line Regimen in Bladder Cancer Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
Post-Immunotherapy Combo Promising in Advanced RCC Duration of response reaches 18.6 months with belzutifan plus cabozantinib Apr 03, 2023
Neuromodulation of the Peroneal Nerve Safe for Overactive Bladder Was also as effective as solifenacin in the majority of assessed efficacy endpoints Mar 24, 2023
Treating Gender Nonconforming Youth Goes Beyond the Physical We must approach care for every patient from the lens of treating the entire individual Mar 15, 2023
Gender-Affirming Surgery Gets a Boost After California Law Kicked In Nondiscrimination law bars insurers from limiting benefits based on gender identity, expression Mar 14, 2023
Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancers ZIRCON trial meets sensitivity and specificity targets Mar 13, 2023
A Surge in Vasectomies: Sustaining the Demand To increase participation, let's reduce the points of friction Mar 13, 2023
Daily Thiazide No Help in Preventing Recurrent Kidney Stones Three different dosages of hydrochlorothiazide no better than placebo Mar 01, 2023
Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subset Over 50% of patients with advanced MET-driven tumors responded to savolitinib plus durvalumab Feb 24, 2023
FDA OKs Sparsentan for IgA Nephropathy-Related Proteinuria Non-immunosuppressive therapy led to 50% reduction in proteinuria Feb 21, 2023
Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer KEYNOTE-057 trial results suggest DFS benefit for patient population with unmet need Feb 19, 2023
Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomy But add-on abiraterone and apalutamide may offer some benefits in those with higher PSA Feb 18, 2023
Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPC Final PROpel analysis also shows trend toward overall survival improvement with PARP inhibitor Feb 17, 2023
Adding Talazoparib to Enzalutamide Boosts PFS in Metastatic Prostate Cancer Combination achieved a 37% reduction in risk of progression, death versus ARPI alone Feb 17, 2023
Rucaparib Gets a Win in Metastatic Castration-Resistant Prostate Cancer Benefit in selected patients seen over physician's choice of docetaxel or second-generation ARPI Feb 16, 2023
If It Resembles Cancer but Doesn't Act Like Cancer, Is It Cancer? Physicians must consider patient perspectives on the Gleason 6 debate Feb 16, 2023
Hormone Infusion Shows Promise for Low Sexual Desire Pair of trials demonstrated efficacy in hypoactive sexual desire disorder Feb 03, 2023
Gender-Affirming Hormones Boost Mental Health for Transgender Youth Gains seen in appearance congruence paired with drops in depression and anxiety, study showed Jan 18, 2023
Short-Course Apalutamide to Reduce Active Surveillance Attrition in Prostate Cancer Editorialists question whether any intervention violates principles of surveillance Jan 17, 2023
MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
5-ARIs Not Linked to Risk of Dementia Over the Long Term However, finasteride and dutasteride were associated with an increased risk of depression Dec 22, 2022
One Doc's Win for Trans Youth Healthcare in Texas A Dallas endocrinologist can continue to provide hormone therapy and puberty blockers Dec 16, 2022
FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Half of patients achieved complete responses with adenoviral vector-based product Dec 16, 2022
MRI-Targeted Biopsy for Prostate Cancer Reduces Risk of Overdiagnosis Though at the cost of delayed diagnosis of some clinically significant cancers Dec 07, 2022
Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients? Barriers exist in identifying risk, but strategies are available Dec 06, 2022
Aging U.S. Population a Challenge for Oncologists Older patients will have different care goals, preferences, geriatric oncologist says Dec 05, 2022
A Dangerous Chilling Effect in Gender-Affirming Care Gender-affirming facilities must continue offering information and resources, despite threats Dec 03, 2022
To Combat Opioid Epidemic, Step Up Safe Prescribing Practices, Expert Urges Overprescribing a continuing problem, Benjamin Davies tells urologists Dec 02, 2022
Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumors Approach in small ongoing trial resulted in reduction in tumor size and complexity Dec 02, 2022
Sequential Gemcitabine/Docetaxel Promising in NMIBC After BCG Relapse But patients with BCG-refractory disease may be better suited for cystectomy Dec 02, 2022
Overactive Bladder Linked to Multiple Unmet Socioeconomic Needs Findings reinforce existing evidence, identify novel factors, suggest future research Dec 01, 2022
Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancer Surgery or radiation delayed initiation of systemic therapy by 18 months Nov 29, 2022
Exercise During Chemo Shows Benefits for Cardiorespiratory Fitness However, patients who exercise after chemo also ultimately see benefits too Nov 21, 2022
Youth With Gender Dysphoria Hospitalized for Suicidal Ideation Far More Often Inpatient setting offers unique opportunity to provide gender-affirming care, researchers say Nov 16, 2022
Primary Care Visits Prior to Cancer Diagnosis Tied to Lower Mortality Most benefit with annual visits, but even some use linked to better outcomes Nov 16, 2022
Role of Cytoreductive Nephrectomy Unclear for Dedifferentiated Kidney Cancer Thirteen-month survival gain falls short of statistical significance in observational study Nov 10, 2022
Florida Medical Boards Ban Gender-Affirming Care for Kids First state to limit care for trans youth through medical board action Nov 07, 2022
Testosterone Tied to Sustained Weight Loss in Men With Hypogonadism and Obesity Small data set finds large weight reductions over time Nov 04, 2022
Treatment De-Escalation Shows Promise in Testicular Cancer Early trial misses primary PFS endpoint, but "favorable" outcomes seen nonetheless Nov 03, 2022
